CN106975049A - A kind of Yi nationality drug composition of reducing blood pressure and blood fat - Google Patents
A kind of Yi nationality drug composition of reducing blood pressure and blood fat Download PDFInfo
- Publication number
- CN106975049A CN106975049A CN201710158353.8A CN201710158353A CN106975049A CN 106975049 A CN106975049 A CN 106975049A CN 201710158353 A CN201710158353 A CN 201710158353A CN 106975049 A CN106975049 A CN 106975049A
- Authority
- CN
- China
- Prior art keywords
- parts
- blood
- nationality
- blood pressure
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 59
- 239000008280 blood Substances 0.000 title claims abstract description 38
- 210000004369 blood Anatomy 0.000 title claims abstract description 38
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 229940079593 drug Drugs 0.000 title claims abstract description 26
- 230000036772 blood pressure Effects 0.000 title claims abstract description 23
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 13
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 13
- 235000014266 Geum aleppicum Nutrition 0.000 claims abstract description 13
- 241000123870 Geum aleppicum Species 0.000 claims abstract description 13
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 13
- 235000013976 turmeric Nutrition 0.000 claims abstract description 13
- 241000155172 Cymbaria Species 0.000 claims abstract description 12
- 244000241872 Lycium chinense Species 0.000 claims abstract description 12
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 12
- 241000001348 Phtheirospermum Species 0.000 claims abstract description 12
- 244000157790 Buglossoides arvense Species 0.000 claims abstract description 11
- 235000004256 Buglossoides arvense Nutrition 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 240000001398 Typha domingensis Species 0.000 claims abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract description 16
- 230000001737 promoting effect Effects 0.000 abstract description 14
- 210000004185 liver Anatomy 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 8
- 230000006837 decompression Effects 0.000 abstract description 7
- 201000005577 familial hyperlipidemia Diseases 0.000 abstract description 7
- 238000005728 strengthening Methods 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 6
- 230000001939 inductive effect Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 230000004087 circulation Effects 0.000 abstract description 4
- 201000001320 Atherosclerosis Diseases 0.000 abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 230000000694 effects Effects 0.000 description 14
- 241000700159 Rattus Species 0.000 description 12
- 241000233948 Typha Species 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 241000411851 herbal medicine Species 0.000 description 11
- 108091006146 Channels Proteins 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 10
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 9
- 230000036407 pain Effects 0.000 description 9
- 239000006071 cream Substances 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 239000002893 slag Substances 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 206010019233 Headaches Diseases 0.000 description 5
- 235000012000 cholesterol Nutrition 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 244000025254 Cannabis sativa Species 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 210000003516 pericardium Anatomy 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 208000037093 Menstruation Disturbances Diseases 0.000 description 3
- 206010027339 Menstruation irregular Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010046788 Uterine haemorrhage Diseases 0.000 description 3
- 208000012886 Vertigo Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- ZPBWCRDSRKPIDG-UHFFFAOYSA-N amlodipine benzenesulfonate Chemical compound OS(=O)(=O)C1=CC=CC=C1.CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl ZPBWCRDSRKPIDG-UHFFFAOYSA-N 0.000 description 3
- 208000034158 bleeding Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- -1 is stood Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 231100000889 vertigo Toxicity 0.000 description 3
- UIAGMCDKSXEBJQ-IBGZPJMESA-N 3-o-(2-methoxyethyl) 5-o-propan-2-yl (4s)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate Chemical compound COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)[C@H]1C1=CC=CC([N+]([O-])=O)=C1 UIAGMCDKSXEBJQ-IBGZPJMESA-N 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000032928 Dyslipidaemia Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 241000608847 Gnaphalium Species 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 208000017170 Lipid metabolism disease Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241000013557 Plantaginaceae Species 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 206010042170 Strangury Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 229960004005 amlodipine besylate Drugs 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 2
- 229960000830 captopril Drugs 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 201000005630 leukorrhea Diseases 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 229960000715 nimodipine Drugs 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- RMMXLENWKUUMAY-UHFFFAOYSA-N telmisartan Chemical compound CCCC1=NC2=C(C)C=C(C=3N(C4=CC=CC=C4N=3)C)C=C2N1CC(C=C1)=CC=C1C1=CC=CC=C1C(O)=O RMMXLENWKUUMAY-UHFFFAOYSA-N 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 235000015763 Artemisia ludoviciana Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241001072256 Boraginaceae Species 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 239000005537 C09CA07 - Telmisartan Substances 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008617 Cholecystitis chronic Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 235000009709 Geum japonicum Nutrition 0.000 description 1
- 241001618015 Geum japonicum Species 0.000 description 1
- 244000067676 Gnaphalium affine Species 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 241001106041 Lycium Species 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000962174 Onosma paniculata Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- 241000001350 Pterygiella tenuisecta Species 0.000 description 1
- 201000003099 Renovascular Hypertension Diseases 0.000 description 1
- 206010039020 Rhabdomyolysis Diseases 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241000195974 Selaginella Species 0.000 description 1
- 241000155668 Siphonostegia chinensis Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 241001518821 Typha orientalis Species 0.000 description 1
- 241000233945 Typhaceae Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229960000528 amlodipine Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229940099352 cholate Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000035603 choleresis Effects 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229960005187 telmisartan Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a kind of Yi nationality's drug composition of reducing blood pressure and blood fat, it is characterised in that is made by following raw material：15 25 parts of finelydivided phtheirospermum root, 20 35 parts of Cymbaria dahurica, 5 10 parts of cattail pollen, 15 20 parts of the root bark of Chinese wolf-berry, 6 10 parts of rhizoma alismatis, 10 15 parts of HERBA SIPHONOSTEGIAE, 36 parts of turmeric, 12 15 parts of aleppo avens herb, 10 15 parts of Asian puccoon；The present composition has promoting blood circulation decompression, changes turbid lipid-loweringing, broken stasis of blood promoting the circulation of qi, inducing meastruation to relieve menalgia, qi-restoratives strengthening the essence, the function of soothing the liver nourishing heart, it is to be used to treat and prevent hypertension, hyperlipemia, atherosclerosis can effectively be prevented and treated, and composition production technique is simple, suitable for industrialized production and marketing application.
Description
Technical field
The present invention relates to a kind of drug regimen with lowering blood pressure and blood fat function, particularly using ethnic drug to be main former
The reducing blood pressure and blood fat Yi nationality drug composition of material.
Background technology
Yi Nationality Medicine experienced thousands of years time, understanding, the process put into practice, recognized again again, have accumulated abundant diseases prevention
Cure the disease experience, develop into a huge treasure-house.State Council leader points out in national work of Chinese medicine meeting in 2004：
" national medicine ensure body health of people in terms of also play an important role, conscientiously to carry out excavation, arrangement, summary,
Work is improved, its development of making greater efforts to promote." 2005 years, State Council《Implement<The Law of the People's Republic of China on the Autonomy of Ethnic Minority Regions>It is some
Regulation》In be just already indicated above：" people's governments at all levels should increase the input to national medicine cause, protection, support and development of national
Medicine and pharmacology." it is all these be provided to effectively to protect with development of national medicine, make from it is national, protect national health money
Source is able to develop and made full use of, while also embodying the great attention that country develops to national medicine.
With the continuous improvement of people's living standards, high protein, high cholesterol, higher unsaturated fatty acid, high salt, high heat are eaten
The excessive intake of thing, and there is the bad life styles such as long-term smoking, anxiety, diet structure is destroyed so that blood pressure is inclined
High, Hyperlipidemia turns into commonplace phenomenon, and the trend risen with rejuvenation is presented.It is reported that China is at present with height
Blood pressure people surpasses 300,000,000, wherein 50% with dyslipidemia, high blood pressure influences each other with dyslipidemia, so as to further increase the heart
The danger of vascular diseases.Therefore, preventing and treating of the control blood fat to cardiovascular and cerebrovascular diseases has great importance while decompression.
Conventional drug for hypertension mainly has calcium channel blocker, AngiotensionⅡ inhibitor and ACE-I tri- big at present
Class, mainly based on Nimodipine, Telmisartan, captopril；Western medicine blood lipid-lowering medicine be based on Statins, but this
A little medicine long-term takings can produce dependence and many adverse reaction and side effect, and such as Nimodipine can cause intestines and stomach
The symptoms such as bleeding, decrease of platelet, skin irritation, it is bad anti-that captopril can produce injury of kidney and palpitaition, vomiting, faintness etc.
Should, Statins easily causes the side effects such as rhabdomyolysis, myalgia, and can control blood fat while decompression without a
Medicine, medical expense is higher.
Compared with Western medicine, the uniqueness such as the high security of traditional Chinese medicine, low adverse reaction, multicomponent, Mutiple Targets, wholistic therapy
Advantage gradually shows, and Yi nationality's medicine as tcm field one greatly have national characters rarity, its potentiality and superiority are not sayed
And explain, with boundless development prospect.
The content of the invention
There is hypotensive activity it is an object of the invention to provide one kind, while Yi nationality's medicine combination of blood fat balance can be adjusted
Thing, the problem of to solve to propose in background technology, the present invention carries out formula design based on Yi nationality's medicine, with finelydivided phtheirospermum root（It is puckery not all）、
Cymbaria dahurica（Machine can rise）, cattail pollen be monarch drug in a prescription, mental-tranquilization, promoting blood circulation decompression；With the root bark of Chinese wolf-berry（Closely can slag）, rhizoma alismatis, HERBA SIPHONOSTEGIAE（It is puckery
It is blue or green）For ministerial drug, heat-clearing improving eyesight, damp-clearing pain-relieving, the turbid lipid-loweringing of change, while strengthening reducing blood pressure and blood fat effect, are worked along both lines；With ginger
Yellow, aleppo avens herb（Miaow vegetarian）For adjutant, broken stasis of blood promoting the circulation of qi, inducing meastruation to relieve menalgia, enriching yin and nourishing kidney strengthen the work(of reducing blood pressure and blood fat
Effect, while supplementing kidney qi；With Asian puccoon（The straight slag of cloth）To make medicine, priming enters pericardium channel, Liver Channel, and focus of going directly, each medicine gives full play to
Monarch relation, promoting blood circulation is depressured, changes turbid lipid-loweringing, and qi-restoratives strengthening the essence, soothing the liver nourishing heart are adjusted comprehensively to body, more efficient
Treat hypertension, hyperlipemia disease.
It is an object of the invention to carry forward Chinese TCM Culture, depth excavates Yi nationality's medicine value with national characters.
In order to realize foregoing invention purpose, the present invention provides following technical scheme：
There is promoting blood circulation decompression the invention provides one kind, change turbid lipid-loweringing, broken stasis of blood promoting the circulation of qi, inducing meastruation to relieve menalgia, qi-restoratives strengthening the essence, soothing the liver nourishing heart
Function, Yi nationality's drug composition of safe and effective reducing blood pressure and blood fat, in parts by weight, it is made up of the following raw material：
Finelydivided phtheirospermum root（It is puckery not all）15-25 parts, Cymbaria dahurica（Machine can rise）20-35 parts, 5-10 parts of cattail pollen, the root bark of Chinese wolf-berry（Closely can slag）15-
20 parts, 6-10 parts of rhizoma alismatis, HERBA SIPHONOSTEGIAE（Puckery green grass or young crops）10-15 parts, 3-6 parts of turmeric, aleppo avens herb（Miaow vegetarian）12-15 parts, purple
Grass（The straight slag of cloth）10-15 parts.
Effect of following taste Chinese medicine is introduced separately below and cures mainly disease：
It is puckery not all, Chinese medicine name finelydivided phtheirospermum root, alias moellendorf spikemoss herb, be Scrophulariaceae Pheheirospermum japonicum platymiscium (Phtheirospermum tenuisectum Bur. et Franch) perennial short and small draft, with root, all herbal medicine.Be distributed in Qinghai, Sichuan, Guizhou,
Yunnan, Tibet, free translation are cardiopathic medicine, and document is recorded：Its mild-natured, pungent hardship.Thoughts of returning home warp, reposes with feeling at ease, hemostasis
Effect.《Yi nationality's medicine book on Chinese herbal medicine》It is recorded to cure mainly：Nervous palpitaition, arrhythmia cordis, insomnia and dreamful sleep, vertigo, hypertension.
Machine can rise, Chinese medicine name Cymbaria dahurica, the big affine cudweed of alias, be composite family Gnaphalium (Gnaphalium affine
D.Don) perennial herb, all herbal medicine is distributed mainly on the ground such as Yunnan, Sichuan,《Yi nationality's medicine book on Chinese herbal medicine》It is recorded to cure mainly outside
Sense cough, tracheitis cough, document record its sweet, slight bitter, and property is pungent, puts down.With preventing phlegm from forming and stopping coughing, clearing heat and promoting diuresis, promoting blood circulation decompression
Effect.
Cattail pollen, Typhaceae plant raupo cattailTypha angustifoliaL., typha orientalisTypha orientalisPreslOr the dry pollen of congener.It is sweet, mild-natured, Return liver, pericardium channel, tool hemostasis, stagnation resolvation is treating stranguria
Effect.For spitting blood, bleeding from five sense organs or subcutaneous tissue, spitting of blood, uterine bleeding, traumatism and bleeding, closed dysmenorrhea, chest and abdomen shouting pain, tumbling and swelling, blood strangury and dry pain.Its
Containing phytosterols such as sitosterol, stigmasterol, campesterols, zoopery also proves substantially suppress the exogenous courage of intestinal absorption
Sterol, promotes it to be discharged in excrement, so as to play a part of reducing blood fat, and can have atherosclerosis and reduction blood
Clear sterol.
Nearly river slag, the Chinese medicine name root bark of Chinese wolf-berry, alias matrimony vine beans, Solanaceae (Lycium chinenseMill) overgrow undershrub,
Root is taken to be used as medicine, document records its sweet-bitter flavor, cool in nature, returns liver and kidney channel, with qi-restoratives strengthening the essence, heat-clearing is quenched the thirst, the work(of dispelling pathogenic wind for improving eyesight
Effect, be mainly used in main caused by liver and kidney deficiency, blurred vision, soreness and weakness of waist and knees, quench one's thirst draw drink etc. disease.《Yi nationality's medicine book on Chinese herbal medicine》Record it and cure mainly high blood
Press, toothache caused by fire of deficiency type, the disease such as phlegm-accumulating vertigo.
Rhizoma alismatis, Notes On Alism At Aceae rhizoma alismatisAlisma orientale（Sam.）Juzep. dry tuber.It is sweet, light,
It is cold in nature.Return kidney, bladder warp.With clearing damp and promoting diuresis, expel the heat-evil, change effect of turbid lipid-loweringing.For difficult urination, oedema turgor, diarrhea
Oliguria, phlegmatic vertigo, puckery pain of heat gonorrhea, hyperlipidemia.Animal experiment study shows, hence it is evident that suppress rabbit aorta atherosclerotic plaque
Formation and its cholesterolemia content, mouse intestines can be suppressed to cholesterol absorption and internal cholesterol biosynthesis, contribute to courage consolidate
The operating and excretion of alcohol.Absorption, decomposition and Excretion with interference cholesterol.
Puckery green grass or young crops, Chinese medicine name HERBA SIPHONOSTEGIAE, alias siphonstegia chinensis, Scrophulariaceae siphonstegia chinensis category (Siphonostegia chinensis
Benth) annual herb, all herbal medicine.Main product is in Jiangsu, Anhui, Zhejiang, Yunnan, Guangxi and other places.Document records that its is cold in nature,
Slight bitter；With clearing heat and promoting diuresis, cooling blood and hemostasis, effect of stasis-dispelling and pain-killing, for treating jaundice, difficult urination, oedema abdominal distension falls damage
Stasis caused pain, bloody flux, blood strangury, leukorrhea, irregular menstruation, a lump in the abdomen causing distension and pain, and postpartum stops stasis of blood stomachache.《Yi nationality's medicine book on Chinese herbal medicine》It is recorded to cure mainly：
Icterepatitis, chronic cholecystitis, the disease such as Hypertension Complicated Headache.
Turmeric, zingiberaceous plant turmericCurcuma Longa L. dry rhizome.Pungent, hardship, it is warm-natured.Returns spleen, Liver Channel.Tool
There are blood-breaking, inducing meastruation to relieve menalgia effect.For chest side of body shouting pain, chest is fought pained, and dysmenorrhoea Amenorrhea , Disorder lumps in the abdomen, rheumatism shoulder arm pain is fallen
Flutter and swell and ache.Document, which records turmeric, can promote choleresis, and the blood courage that its extract can obviously reduce Experimental Hyperlipemia animal is consolidated
Alcohol content.Turmeric alcohol extracting thing, volatile oil and curcumin play the role of reduction cholesterolemia, triglycerides and beta Lipoprotein, with
Triglyceride reducing is most notable, and can reduce cholesterol, content of triglyceride in sustainer.
Miaow vegetarian, Chinese medicine name aleppo avens herb, alias dizziness medicine, aleppo avens, throatroot, rose family throatroot category (Geum japonicum Thbg.var.chinense F.Bolle) perennial herb, all herbal medicine.Document records its acrid-sweet flavor, property
Temperature, with enriching yin and nourishing kidney, flat liver improving eyesight, promoting blood circulation and stopping pain, adjusting meridian and stopping leukorrhea, cures mainly main sore, carbuncle and painful swelling, aphtha pharyngalgia, injuries from falls as well,
Under arthralgia pain due to rheumatism, diarrhea dysentery abdominal pain, irregular menstruation, uterine bleeding band, tinea pedis oedema, child convulsion.《Yi nationality's medicine book on Chinese herbal medicine》It is recorded to cure mainly：Head
Confused dizzy, god declines physically weak, irregular menstruation, under uterine bleeding band, chronic hepatitis, chronic bronchitis, hypertension, low blood pressure, hypoglycemia.
The straight slag of cloth, Chinese medicine name Asian puccoon, alias purple grass, Boraginaceae radix onosmae category（Onosma paniculatum Bur.et
Fr）Perennial herb, all herbal medicine, distribution Yunnan and Tibet, Sichuan.《Yi nationality's medicine book on Chinese herbal medicine》Record that its mainly for treating mammary gland inflammation Collapse is broken not to be received
Mouthful, adult's treating child hyperpyrexia.Document records its sweet-salty, cold in nature, enters pericardium channel, Liver Channel, and with cool blood, promoting blood circulation, removing toxic substances is saturating
Rash, anti-inflammatory analgetic.For blood-heat and toxin exuberance, measles without adequate eruption, the disease such as scald.Modern pharmacology clinical trial shows that it has very
Good antihypertensive effect.
Yi nationality's drug composition of reducing blood pressure and blood fat of the present invention can be routinely Traditional Chinese medicine extraction method extract raw material activity
Component, along with pharmaceutically acceptable auxiliary material, be made granule suitable in pharmacy, oral liquid, tablet, capsule,
The common dosage forms such as pill.
Yi nationality's drug composition of reducing blood pressure and blood fat of the present invention, the extracting method of raw material can be used but is not limited to lower section
Method：
Finelydivided phtheirospermum root, Cymbaria dahurica, cattail pollen, the root bark of Chinese wolf-berry, rhizoma alismatis, HERBA SIPHONOSTEGIAE, turmeric, aleppo avens herb, Asian puccoon are weighed by proportioning, is mixed
Add water, amount of water is 8-10 times of composition quality, and 1-2h is handled at 60-70 DEG C, filter after conjunction, filter residue adds filter residue quality 8-10
Water again is reprocessed 1-2 times, merging filtrate, and 60 DEG C -70 DEG C of filtrate is concentrated into the clear cream that relative density is 1.20-1.30；
Mass percent concentration 75-85% ethanol solution is added in clear cream, is stood, supernatant is taken, ethanol is removed, obtains refined liquid；Essence
Liquid processed is concentrated and dried, and produces Yi nationality's drug composition.
Each component gives full play to monarch relation in Yi nationality's drug composition of reducing blood pressure and blood fat of the present invention, decompression of invigorating blood circulation,
Change turbid lipid-loweringing, broken stasis of blood promoting the circulation of qi, qi-restoratives strengthening the essence, inducing meastruation to relieve menalgia, qi-restoratives strengthening the essence, soothing the liver nourishing heart are adjusted, more comprehensively to body
Effectively treat hypertension, hyperlipemia disease；It is mainly used in hypertension, hyperlipemia, effectively prevents and treats atherosclerosis；Present invention production
Product simple production process, can be made into various preparations, suitable for industrialization production and marketing application.
Embodiment
Below by embodiment, the present invention will be described in further detail, but the scope of the present invention be not limited to it is described
Content.
Embodiment 1：Yi nationality's drug composition of this reducing blood pressure and blood fat is made by following raw material：Finelydivided phtheirospermum root 15g, Cymbaria dahurica
20g, cattail pollen 5g, root bark of Chinese wolf-berry 15g, rhizoma alismatis 6g, HERBA SIPHONOSTEGIAE 10g, turmeric 3g, aleppo avens herb 12g, Asian puccoon 10g；
Preparing for above-mentioned composition is as follows：
Finelydivided phtheirospermum root, Cymbaria dahurica, cattail pollen, the root bark of Chinese wolf-berry, rhizoma alismatis, HERBA SIPHONOSTEGIAE, turmeric, aleppo avens herb, Asian puccoon, group are weighed by proportioning
Compound, which adds water, to be handled three times, adds 1.5h is handled at the water of 10 times of composition quality, 60 DEG C for the first time, and filtering filter residue adds filter for the second time
The water that 8 times of slag amount, 8 times of 1h, filtering filter residue third time plus filter residue quality water are handled at 60 DEG C, 60 DEG C, 1h is handled, merges filter
Liquid, 60 DEG C are concentrated into the clear cream that relative density is 1.30；The ethanol solution of mass percent concentration 80% is added in clear cream, it is quiet
12h is put, supernatant is taken, ethanol is removed, obtains refined liquid；Refined liquid is concentrated and dried, and produces Yi nationality's drug composition.
Embodiment 2：Yi nationality's drug composition of this reducing blood pressure and blood fat is made by following raw material：Finelydivided phtheirospermum root 20g, Cymbaria dahurica 25g,
Cattail pollen 10g, root bark of Chinese wolf-berry 17g, rhizoma alismatis 10g, HERBA SIPHONOSTEGIAE 15g, turmeric 6g, aleppo avens herb 13g, Asian puccoon 15g；
Preparing for above-mentioned composition is as follows：
Finelydivided phtheirospermum root, Cymbaria dahurica, cattail pollen, the root bark of Chinese wolf-berry, rhizoma alismatis, HERBA SIPHONOSTEGIAE, turmeric, aleppo avens herb, Asian puccoon, group are weighed by proportioning
Compound, which adds water, to be handled three times, the water of 10 times of first time plus composition quality, and 65 DEG C of processing 1.5h, filtering filter residue adds filter residue for the second time
The water of 9 times of the water that 9 times of quality, 65 DEG C of processing 1h, filtering filter residue third time plus filter residue quality, 65 DEG C of processing 1h, merging filtrate, 70
DEG C it is concentrated into the clear cream that relative density is 1.2；The ethanol solution of mass percent concentration 75% is added in clear cream, 12h is stood,
Supernatant is taken, ethanol is removed, obtains refined liquid；Refined liquid is concentrated and dried, and produces Yi nationality's drug composition.
Embodiment 3：Yi nationality's drug composition of this reducing blood pressure and blood fat is made by following raw material：Finelydivided phtheirospermum root 25g, Cymbaria dahurica 35g,
Cattail pollen 8g, root bark of Chinese wolf-berry 20g, rhizoma alismatis 9g, HERBA SIPHONOSTEGIAE 12g, turmeric 5g, aleppo avens herb 15g, Asian puccoon 13g；
Preparing for above-mentioned composition is as follows：
Finelydivided phtheirospermum root, Cymbaria dahurica, cattail pollen, the root bark of Chinese wolf-berry, rhizoma alismatis, HERBA SIPHONOSTEGIAE, turmeric, aleppo avens herb, Asian puccoon, group are weighed by proportioning
Compound, which adds water, to be handled three times, the water of 10 times of first time plus composition quality, and 60 DEG C of processing 2h, filtering filter residue adds filter residue matter for the second time
The water of 8 times of the water of 8 times of amount, 60 DEG C of processing 1.5h, filtering filter residue third time plus filter residue quality, 60 DEG C of processing 1h, merging filtrate, 65
DEG C it is concentrated into the clear cream that relative density is 1.30；The ethanol solution of mass percent concentration 85% is added in clear cream, 12h is stood,
Supernatant is taken, ethanol is removed, obtains refined liquid；Refined liquid is concentrated and dried, and produces Yi nationality's drug composition.
Pharmacological experiment：
Experiment material：Yi nationality's drug composition made from above-described embodiment；Amlodipine besylate tablets, purchased from Pfizer；0.9% life
Manage salt solution.
Laboratory apparatus：0.25mm " Ω " shapes silver brain clip (Ke Yuan Medical Devices Co., Ltd.s), big mouse non-invasive blood pressure instrument
Softron BP-98A；
Experimental animal：SPF grades of rats (Beijing Vital River Experimental Animals Technology Co., Ltd.) 40, male and female half and half, body weight
200 ± 35g, sub-cage rearing, per 1, cage, 22~24 DEG C of room temperature, ad lib is drunk water 1 week.Goldblatt methods replicate two kidneys
One folder Renovascular Hypertension Rats, that is, stabilize (5mg/kg)+ketamine (50mg/kg) anesthesia, and dissociate the left side arteria renalis, uses
Internal diameter 0.25mm " Ω " shape silver brain clip is clamped, and offside kidney is not touched.Rat feeds high lipid food (basal feed 82.3%, cholesterol
2.0%th, cholate, 0.5%, lard 10%, yolk powder 5%, propylthiouracil 0.2%), continue to that experiment terminates, postoperative
6 weeks rat blood pressures are considered as modeling success up to more than 160mmHg.
Experiment packet and administration
By the successful hypertension of above-mentioned modeling with hyperlipemia rat 40,5 groups are randomly divided into, every group 8,5 groups of experimental groups are set,
1st group be model group, 0.9% physiological saline gavage, once in the morning and once at night, each 3mL；2nd group is Amlodipine Besylate Tablet group, benzene
Sulfonic acid amlodipine daily 5mg/, gavage；3rd, 4,5 groups be respectively the composition of embodiment 1,2,3, given low is every
Secondary 2g/kg, 3 times a day.
All rat ad libs and drinking-water, are administered 4 weeks.Daily observation diet and active situation, measurement body weight, and according to
Body weight adjusts drug dose, and an arteria caudalis blood pressure measurement is carried out every two weeks.After experiment terminates, abdominal aortic is extracted in anesthesia
Blood, TC, TG, HDL-C, LDL-C are determined with ELISA method.
Experimental result：Statistical procedures are carried out with SPSS19.0 statistical analysis softwares, experimental data carries out variance analysis,
As a result represented with x ± s.
Influence result (n=8) of each group of table 1 to rat blood pressure, unit：mmHg
；
Compared with model group：* P ＜ 0.05, above-described embodiment composition group can efficiently reduce the blood pressure of Hypertensive Rats, poor
It is different that there is statistical significance.
After experiment terminates above, TC, TG, HDL-C, LDL-C level of each group rat are measured.Statistical result see the table below；
；
Compared with model group, P ＜ 0.05, above-described embodiment composition group can effectively reduce rat model blood fat, difference has
Statistical significance.
By daily to rat it has been observed that 1,3,4,5 groups of signs it is normal, activity is normal, and 2 groups have 1 rat to go out
Existing oedema phenomenon.Experiment proves that above-described embodiment composition group can effectively reduce the hypertension, hyperlipemia of rat.
Clinically screening hypertension is equally divided into 2 groups, control group is conventional treatments with hyperlipemic patients 128,
Treatment group's tablet made from the composition conventional method in above-described embodiment（Composition accounts for the 71.6% of tablet quality）, often
It 3 times, 3~5 every time, 60 days are even served, wherein control group there are 2 people, treatment group has 1 people not adhere to, and it is invalid to be designated as, and patient is general
Often occur the diseases such as headache, tinnitus, palpitation, extremity numbness, dizziness, blood pressure detects that blood fat is with channel collateral instrument with conventional blood pressure instrument
The heart channel of Hang-Shaoyin and pericardium channel are detected, as a result be see the table below：
；
Typical case is as follows：
Zhang, female, 69 years old, people from Chuxiong.It is diagnosed as hypertension, One's spirits are drooping, headache, palpitation, 2013 in March, 2012
June in year starts to take above-described embodiment composite preparation, takes headache relief after 5 days, continues to take after 3 courses for the treatment of, is discontinued, with
Visit is not recurred so far.
Zeng, female, 50 years old, Chuxiong Yuanmou County people started headache tinnitus, dizziness occur for 2013, the situation such as palpitaition, sometimes
Also with extremity numbness, after diagnosing with hypertension, symptom mitigation after above-described embodiment composite preparation, 1 course for the treatment of is taken, after
Continuous take is discontinued after 2 courses for the treatment of, and follow-up is not recurred so far.
Yang, man, 42 years old, with hypertension, high fat of blood, often there is head and hangs dizzy, palpitaition ear in Chuxiong people from Nanhua County
Ring, the symptom of extremity numbness, start to take symptom after above-described embodiment composite preparation, 1 course for the treatment of for 2014 and mitigate significantly, essence
God recovers, and continues to take and is discontinued after 3 courses for the treatment of.
Claims (1)
1. Yi nationality's drug composition of a kind of reducing blood pressure and blood fat, it is characterised in that be made by following raw material：Finelydivided phtheirospermum root 15-25
Part, 20-35 parts of Cymbaria dahurica, 5-10 parts of cattail pollen, 15-20 parts of the root bark of Chinese wolf-berry, 6-10 parts of rhizoma alismatis, 10-15 parts of HERBA SIPHONOSTEGIAE, turmeric 3-6
Part, 12-15 parts of aleppo avens herb, 10-15 parts of Asian puccoon.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710158353.8A CN106975049A (en) | 2017-03-17 | 2017-03-17 | A kind of Yi nationality drug composition of reducing blood pressure and blood fat |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710158353.8A CN106975049A (en) | 2017-03-17 | 2017-03-17 | A kind of Yi nationality drug composition of reducing blood pressure and blood fat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106975049A true CN106975049A (en) | 2017-07-25 |
Family
ID=59338101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710158353.8A Pending CN106975049A (en) | 2017-03-17 | 2017-03-17 | A kind of Yi nationality drug composition of reducing blood pressure and blood fat |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106975049A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020103077A (en) * | 2018-12-26 | 2020-07-09 | 武田コンシューマーヘルスケア株式会社 | Blood pressure lowering composition |
| CN114767768A (en) * | 2022-05-10 | 2022-07-22 | 楚雄医药高等专科学校 | Yi medicine composition for reducing blood pressure and blood fat and preparation method thereof |
-
2017
- 2017-03-17 CN CN201710158353.8A patent/CN106975049A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| 孙炜华: "《糖尿病药膳疗法》", 31 May 2005, 上海科学技术文献出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020103077A (en) * | 2018-12-26 | 2020-07-09 | 武田コンシューマーヘルスケア株式会社 | Blood pressure lowering composition |
| JP7253372B2 (en) | 2018-12-26 | 2023-04-06 | アリナミン製薬株式会社 | antihypertensive composition |
| CN114767768A (en) * | 2022-05-10 | 2022-07-22 | 楚雄医药高等专科学校 | Yi medicine composition for reducing blood pressure and blood fat and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104666579A (en) | Traditional Chinese medicine composition for treating gonarthromeningitis and preparation method of traditional Chinese medicine composition | |
| CN102078569B (en) | Traditional Chinese medicine preparation for treating liver cancer and preparation method thereof | |
| CN106177053A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja and Pericarpium Citri Reticulatae | |
| CN103520655A (en) | Traditional Chinese medicine composition for treating psoriasis vulgaris and preparation method thereof | |
| CN103041256A (en) | Chinese herb preparation for curing recurrent respiratory tract infection of children | |
| CN103041257B (en) | Chinese materia medica preparation for curing high fever and respiratory tract infection of children | |
| CN106975049A (en) | A kind of Yi nationality drug composition of reducing blood pressure and blood fat | |
| CN103041255B (en) | Chinese materia medica preparation for curing swollen sore throat and respiratory tract infection of children | |
| CN105435197A (en) | Pharmaceutical composition for treating chronic lymphocytic thyroiditis and preparation method thereof | |
| CN103845535A (en) | Pharmaceutical composition for debriding and eliminating inflammation | |
| CN103735906A (en) | Chinese herb preparation for treating dry bronchiectasis and preparation method thereof | |
| CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
| CN114712466B (en) | Medicine with weight-reducing and beautifying effects and preparation method thereof | |
| CN103041258B (en) | Chinese materia medica preparation for curing respiratory tract infection with poor appetite of children | |
| CN103933427A (en) | Pharmaceutical composition for treating nodular syphiloderm and preparation method thereof | |
| CN105248770A (en) | Danshen root leaf health tea capable of reducing blood fat and preparation method of Danshen root leaf health tea | |
| CN104689073A (en) | Medicine for treating yin deficiency and heat-poison type lung cancer and preparation method thereof | |
| CN103041259B (en) | Chinese materia medica preparation for curing excessive phlegm, cough and respiratory tract infection of children | |
| CN104707003B (en) | The Chinese medicinal capsule for the treatment of hypertension, hyperlipidemia | |
| CN108635521A (en) | A kind of topical composition and preparation method thereof for treating burn and scald | |
| CN108159306A (en) | Medicine for treating drug sores and preparation method thereof | |
| CN104587269A (en) | Medicament for treating liver-stomach heat type chronic gastritis, and preparation method | |
| CN106798836A (en) | A kind of Yi nationality's medicine strengthening the spleen and stomach composition | |
| CN104906516A (en) | Traditional Chinese medicinal composition for treating coronary heart disease and preparation method of traditional Chinese medicinal composition | |
| CN106177534A (en) | A kind of Chinese medicine composition treating stomach network stasis type duodenojejunal dudenal stasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170725 |
|
| RJ01 | Rejection of invention patent application after publication |